Phencyclidine-induced head-twitch response in rats treated chronically with methysergide

Toshitaka Nabeshima, Kazuhiro Ishikawa, Kazumasa Yamaguchi, Hiroshi Furukawa, Tsutomu Kameyama

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

This study was designed to assess whether phenycyclidine (PCP)-induced behaviors in rats were potentiated after two days' withdrawal from chronic methysergide (a 5-HT2 receptor blocker) treatment (10 mg/kg per day i.p. for 12 days), in order to confirm the involvement of 5-hydroxytryptamine (5-HT) neurons in PCP actions. The PCP (10 mg/kg)-induced behaviors (head-twitch, head-weaving, turning and backpedalling) were attenuated by successive pretreatment with PCP (10 mg/kg per day i.p. for 12 days), while PCP- and 5-methoxy-N,N-dimethyltryptamine (2 mg/kg)-induced head-twitch increased significantly after the repeated methysergide treatment was stopped. The development of tolerance to PCP-induced head-twitch was antagonized by pretreatment with methysergide. Furthermore, Scatchard plots of specific [3H]ketanserin binding at the 5-HT2 receptors and [3H]PCP binding at the PCP receptors in the methysergide group revealed significant increases in binding capacity (Bmax) with no change in affinity (Kd). On the contrary, after development of tolerance to PCP, there were significant decreases in Bmax of [3H]ketanserin binding with no change in affinity. PCP can thus place [3H]ketanserin at the 5-HT2 receptor site, but not [3H]5-HT at the 5-HT1 receptor site. These facts indicate that PCP may produce head-twitch via an agonistic interaction with 5-HT2 receptor sites.

Original languageEnglish
Pages (from-to)319-328
Number of pages10
JournalEuropean Journal of Pharmacology
Volume133
Issue number3
DOIs
Publication statusPublished - 20-01-1987
Externally publishedYes

Fingerprint

Methysergide
Phencyclidine
Ketanserin
Head
Phencyclidine Receptors
Serotonin
Methoxydimethyltryptamines
Serotonin 5-HT1 Receptors
Neurons

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

Nabeshima, Toshitaka ; Ishikawa, Kazuhiro ; Yamaguchi, Kazumasa ; Furukawa, Hiroshi ; Kameyama, Tsutomu. / Phencyclidine-induced head-twitch response in rats treated chronically with methysergide. In: European Journal of Pharmacology. 1987 ; Vol. 133, No. 3. pp. 319-328.
@article{2e5e4d3f611b4e0d9a29d47f81dd4de1,
title = "Phencyclidine-induced head-twitch response in rats treated chronically with methysergide",
abstract = "This study was designed to assess whether phenycyclidine (PCP)-induced behaviors in rats were potentiated after two days' withdrawal from chronic methysergide (a 5-HT2 receptor blocker) treatment (10 mg/kg per day i.p. for 12 days), in order to confirm the involvement of 5-hydroxytryptamine (5-HT) neurons in PCP actions. The PCP (10 mg/kg)-induced behaviors (head-twitch, head-weaving, turning and backpedalling) were attenuated by successive pretreatment with PCP (10 mg/kg per day i.p. for 12 days), while PCP- and 5-methoxy-N,N-dimethyltryptamine (2 mg/kg)-induced head-twitch increased significantly after the repeated methysergide treatment was stopped. The development of tolerance to PCP-induced head-twitch was antagonized by pretreatment with methysergide. Furthermore, Scatchard plots of specific [3H]ketanserin binding at the 5-HT2 receptors and [3H]PCP binding at the PCP receptors in the methysergide group revealed significant increases in binding capacity (Bmax) with no change in affinity (Kd). On the contrary, after development of tolerance to PCP, there were significant decreases in Bmax of [3H]ketanserin binding with no change in affinity. PCP can thus place [3H]ketanserin at the 5-HT2 receptor site, but not [3H]5-HT at the 5-HT1 receptor site. These facts indicate that PCP may produce head-twitch via an agonistic interaction with 5-HT2 receptor sites.",
author = "Toshitaka Nabeshima and Kazuhiro Ishikawa and Kazumasa Yamaguchi and Hiroshi Furukawa and Tsutomu Kameyama",
year = "1987",
month = "1",
day = "20",
doi = "10.1016/0014-2999(87)90028-8",
language = "English",
volume = "133",
pages = "319--328",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "3",

}

Phencyclidine-induced head-twitch response in rats treated chronically with methysergide. / Nabeshima, Toshitaka; Ishikawa, Kazuhiro; Yamaguchi, Kazumasa; Furukawa, Hiroshi; Kameyama, Tsutomu.

In: European Journal of Pharmacology, Vol. 133, No. 3, 20.01.1987, p. 319-328.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Phencyclidine-induced head-twitch response in rats treated chronically with methysergide

AU - Nabeshima, Toshitaka

AU - Ishikawa, Kazuhiro

AU - Yamaguchi, Kazumasa

AU - Furukawa, Hiroshi

AU - Kameyama, Tsutomu

PY - 1987/1/20

Y1 - 1987/1/20

N2 - This study was designed to assess whether phenycyclidine (PCP)-induced behaviors in rats were potentiated after two days' withdrawal from chronic methysergide (a 5-HT2 receptor blocker) treatment (10 mg/kg per day i.p. for 12 days), in order to confirm the involvement of 5-hydroxytryptamine (5-HT) neurons in PCP actions. The PCP (10 mg/kg)-induced behaviors (head-twitch, head-weaving, turning and backpedalling) were attenuated by successive pretreatment with PCP (10 mg/kg per day i.p. for 12 days), while PCP- and 5-methoxy-N,N-dimethyltryptamine (2 mg/kg)-induced head-twitch increased significantly after the repeated methysergide treatment was stopped. The development of tolerance to PCP-induced head-twitch was antagonized by pretreatment with methysergide. Furthermore, Scatchard plots of specific [3H]ketanserin binding at the 5-HT2 receptors and [3H]PCP binding at the PCP receptors in the methysergide group revealed significant increases in binding capacity (Bmax) with no change in affinity (Kd). On the contrary, after development of tolerance to PCP, there were significant decreases in Bmax of [3H]ketanserin binding with no change in affinity. PCP can thus place [3H]ketanserin at the 5-HT2 receptor site, but not [3H]5-HT at the 5-HT1 receptor site. These facts indicate that PCP may produce head-twitch via an agonistic interaction with 5-HT2 receptor sites.

AB - This study was designed to assess whether phenycyclidine (PCP)-induced behaviors in rats were potentiated after two days' withdrawal from chronic methysergide (a 5-HT2 receptor blocker) treatment (10 mg/kg per day i.p. for 12 days), in order to confirm the involvement of 5-hydroxytryptamine (5-HT) neurons in PCP actions. The PCP (10 mg/kg)-induced behaviors (head-twitch, head-weaving, turning and backpedalling) were attenuated by successive pretreatment with PCP (10 mg/kg per day i.p. for 12 days), while PCP- and 5-methoxy-N,N-dimethyltryptamine (2 mg/kg)-induced head-twitch increased significantly after the repeated methysergide treatment was stopped. The development of tolerance to PCP-induced head-twitch was antagonized by pretreatment with methysergide. Furthermore, Scatchard plots of specific [3H]ketanserin binding at the 5-HT2 receptors and [3H]PCP binding at the PCP receptors in the methysergide group revealed significant increases in binding capacity (Bmax) with no change in affinity (Kd). On the contrary, after development of tolerance to PCP, there were significant decreases in Bmax of [3H]ketanserin binding with no change in affinity. PCP can thus place [3H]ketanserin at the 5-HT2 receptor site, but not [3H]5-HT at the 5-HT1 receptor site. These facts indicate that PCP may produce head-twitch via an agonistic interaction with 5-HT2 receptor sites.

UR - http://www.scopus.com/inward/record.url?scp=0023125737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023125737&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(87)90028-8

DO - 10.1016/0014-2999(87)90028-8

M3 - Article

C2 - 3556394

AN - SCOPUS:0023125737

VL - 133

SP - 319

EP - 328

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 3

ER -